North America Medical Aesthetics Market

Market Introduction

The North America medical aesthetics market is analyzed on the basis of three major countries: the US, Canada, and Mexico. The US holds the largest share of the North American skin aesthetic devices market. The US is expected to be the largest market for the medical aesthetics market owing to several factors such as rising aesthetic procedures, and growing development of non-invasive aesthetic devices. In Canada, the growth of the market is expected to grow due to factors such as rising strategic investments by international players, increasing the number of aesthetic clinics, and growing numbers of medical device players. On the other hand, Mexico is expected to be the fastest-growing market for the medical aesthetic devices market owing to factors such as growing medical tourism and the aesthetic market. The medical aesthetic market in the US is expected to be the largest in the North American region. The growth of the market in the country is defined by various factors, such as the rise in the development of non-invasive medical aesthetic devices, the exponential rise in the aesthetic procedures. In the US, the number of aesthetic procedures has increased significantly over the last ten years. Also, the development of technology has increased the number of minimally and non-invasive procedures. For instance, according to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2008, there were 10.2 million treatments performed in the US. Among these, nearly 80% of the procedures were performed with minimally invasive procedures. In addition, according to ASAPS latest statistics published in 2018, less famous procedures such as thigh lifts, chin augmentation, and breast reduction has increased significantly in past years, they have increased with 24%, 20%, and 18% respectively. Moreover, according to the ASAPS, 2018 statistics, below is the number of top five surgical and non-surgical procedures performed in 2018.

In the US, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care due to an increasing number of COVID-19 patients. This scenario is slowing down the process of innovation. Moreover, the cosmetic surgeons having a unique perspective of working with patients and their teams create difficulties and challenges in the time of distress. Due to the ongoing COVID-19 pandemic, in May 2020, the American Society of Plastic Surgeons (ASPS) released a statement to urge the suspension of elective and nonessential procedures of cosmetic and laser surgeries in the US. The ASPS also stated that the necessary action is likely to result in detrimental financial effect on the aesthetic surgery community. However, the organization is putting in its best efforts to continue the consultations for medical interventions through virtual platforms. The ASPS is encouraging the use of telehealth to arrange the preoperative consults and follow-up appointments of the post-operative patients. In addition, the cosmetic surgery societies are implementing strategies to curb the financial losses and have amended their policies to support small businesses. For instance, Small Business Administration offering expanded disaster impact loans and deferment of the federal income tax payments by three months to July 15.

Market Overview and Dynamics

The medical aesthetics market in North America is expected to grow from US$ 2,512.24 million in 2021 to US$ 5,823.87 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Technological advancements associated with medical aesthetic devices; all medical devices used for various cosmetic procedures, including plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., are categorized under the medical aesthetic products umbrella. Technological advancements in devices, increasing awareness about aesthetic procedures, growing acceptance of minimally invasive devices, and surge in obese population are the main forces boosting the medical aesthetics market growth. With the establishment of the advanced, high-speed internet infrastructure and the growing trend of social media, information is becoming more accessible to everyone, and people are becoming more aware of aesthetic procedures. An increasing number of social media users and the sensitization of the masses to medical aesthetic procedures are being correlated with the improved sales of medical aesthetic devices. The aesthetic outcome in patient demand for cosmetic treatments was influenced by several parameters, such as clinical improvement after surgery, risks and potential complications, and downtime. These parameters could validate plasma technology as a new regenerative modality. The plasma skin regeneration (PSR) technology has great potential in dermatology; it helps treat facial arrhythmias, sun keratosis, seborrheic keratosis, and warts. A few studies have examined the clinical effects of PSR technology on periorbital rejuvenation. With conventional blepharoplasty, more than 90% improvement and with PSR ~20% and 30% improvement in the tightening of the upper eyelid and the periorbital folds, respectively, were achieved. After six months, ~40% improvement in acne scars on the face was achieved after the single PSR treatment. PSR has also been explored for the rejuvenation of the skin of chest, neck, and back of the hands. In addition, it can be used to treat traumatic scars, benign familial pemphigus, and porokeratosis. Understanding the impact of the PSR technology on aesthetic medicine requires the basic knowledge of the physics and histopathological aspects of plasma. Recent advancements in the technology are likely to bring dramatic improvements in the aesthetic treatment of the skin. The emergence of laser and light-based technologies are very promising among skin rejuvenation therapies. New laser resurfacing techniques for skin rejuvenation offer significant advantages over conventional ablative lasers such as the CO2 and erbium-YAG laser systems. Non-ablative and fractional lasers, although not as effective as ablative therapies, are associated with significantly lower complication rates and shorter recovery periods. New devices combining ablative and fractional technologies are available in the medical aesthetics market, and they are showing remarkable results. This is bolstering the growth of the medical aesthetics market.

Key Market Segments

Based on product market is segmented into facial aesthetic products, body contouring devices, cosmetic implants, skin aesthetic devices, hair removal devices, tattoo removal devices and others. In 2020, the facial aesthetic products segment held the largest share of the market, by product. Based on the application market was segmented into facial and body contouring, facial and skin rejuvenation, breast augmentation, hair removal, reconstructive surgery, tattoo removal and others. In 2020, the facial and body contouring segment held the largest share of the market, by application. Based on the end user market was segmented into hospitals, dermatology clinics, medical spas and beauty centers and home care. In 2020, the hospitals segment held the largest share of the market, by end user.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the medical aesthetics market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc, Alma Lasers, Cutera Inc, Galderma, Hologic, Inc., Mentor Worldwide, LLC, Sientra, and Solta Medical among others.

Reasons to buy report

• To understand the North America medical aesthetics market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for North America medical aesthetics market
• Efficiently plan M&A and partnership deals in North America medical aesthetics market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America medical aesthetics market
• Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

NORTH AMERICA MEDICAL AESTHETICS MARKET SEGMENTATION

By Product

• Facial Aesthetic Products
  • Dermal Fillers
  • Botulinum Toxin
  • Microdermabrasion Devices
• Body Contouring Devices
  • Liposuction Devices
  • Nonsurgical Fat Reduction Devices
  • Cellulite Reduction Devices
• Cosmetic Implants
  • Breast Implants
  • Facial Implants
  • Others
• Skin Aesthetic Devices
  • Laser Skin Resurfacing Devices
  • Light Therapy Devices
  • Nonsurgical Skin Tightening Devices
  • Micro-Needling Products
• Hair Removal Devices
• Tattoo Removal Devices
• Others

By Application

• Facial and Body Contouring
• Facial and Skin Rejuvenation
• Breast Augmentation
• Hair Removal
• Reconstructive Surgery
• Tattoo Removal
• Others

By End User

• Hospitals
• Dermatology Clinics
• Medical Spas and Beauty Centers
• Home Care

By Country

• US
• Canada
• Mexico

Company Profiles

• Allergan Plc
• Alma Lasers
• Cutera Inc
• Galderma
• Hologic, Inc.
• Mentor Worldwide, LLC
• Sientra
• Solta Medical

North America Medical Aesthetics Market Strategic Insights

North America Medical Aesthetics Market Segmentation Analysis

North America Medical Aesthetics Market Report Highlights

North America Medical Aesthetics Report Scope

North America Medical Aesthetics Market Country and Regional Insights